Apricus Biosciences to Present at BIO-Europe Spring 2013

Apricus Biosciences to Present at BIO-Europe Spring 2013

SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc.
("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced
today that Edward Cox, Vice President Corporate Development & Investor
Relations, will present at the BIO-Europe Spring 2013 Partnering Conference,
being held in Barcelona, Spain. Mr. Cox's presentation will take place on
Wednesday, March 13, 2013 at 11:00 a.m. Local Time (6:00 a.m. Eastern Time).

A replay of the presentation will be accessible to the public online at the
Company's website at http://www.apricusbio.com.

About Apricus Biosciences, Inc.

Apricus Biosciences, Inc. is a pharmaceutical company that develops and
markets innovative treatments that help large patient populations across
numerous, large-market therapeutic classes including male and female sexual
health. The Company has one approved product, Vitaros®, for the treatment of
erectile dysfunction, which will be marketed in Canada by Abbott Laboratories
and Femprox®, a product candidate, for the treatment of female sexual arousal
disorder, which successfully completed one 400-patient Phase III study in
China.

For further information on Apricus Bio, visit http://www.apricusbio.com. You
can also receive information at http://twitter.com/apricusbio.

CONTACT: Apricus Bio Investor Relations:
         David Pitts
         Argot Partners
         212-600-1902
         david@argotpartners.com

Apricus logo
 
Press spacebar to pause and continue. Press esc to stop.